CN106139366B - Device for delivering a medical device to a heart valve - Google Patents
Device for delivering a medical device to a heart valve Download PDFInfo
- Publication number
- CN106139366B CN106139366B CN201610459051.XA CN201610459051A CN106139366B CN 106139366 B CN106139366 B CN 106139366B CN 201610459051 A CN201610459051 A CN 201610459051A CN 106139366 B CN106139366 B CN 106139366B
- Authority
- CN
- China
- Prior art keywords
- elongate
- distal end
- radially expandable
- heart valve
- cannula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000003709 heart valve Anatomy 0.000 title claims abstract description 59
- 210000002376 aorta thoracic Anatomy 0.000 claims description 17
- 230000017531 blood circulation Effects 0.000 claims description 10
- 210000001765 aortic valve Anatomy 0.000 claims description 9
- 210000000709 aorta Anatomy 0.000 claims description 4
- 230000008439 repair process Effects 0.000 claims description 3
- 230000001174 ascending effect Effects 0.000 claims 1
- 230000003073 embolic effect Effects 0.000 abstract description 36
- 238000000034 method Methods 0.000 description 16
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 210000005166 vasculature Anatomy 0.000 description 7
- 210000003484 anatomy Anatomy 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 238000004873 anchoring Methods 0.000 description 2
- 210000003157 atrial septum Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000004115 mitral valve Anatomy 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 230000002966 stenotic effect Effects 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/011—Instruments for their placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/012—Multiple filtering units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
- A61F2/014—Retrograde blood flow filters, i.e. device inserted against the blood flow direction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
- A61F2/2433—Deployment by mechanical expansion using balloon catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/016—Filters implantable into blood vessels made from wire-like elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/018—Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0071—Three-dimensional shapes spherical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0059—Additional features; Implant or prostheses properties not otherwise provided for temporary
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1047—Balloon catheters with special features or adapted for special applications having centering means, e.g. balloons having an appropriate shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
- A61M2210/125—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Mechanical Engineering (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
A catheter device for transvascular delivery of a medical device to a heart valve region of a patient is disclosed. The catheter device comprises an elongate sleeve (2), the elongate sleeve (2) having a releasable locking member for controllably locking the elongate sleeve in shape at least partially along its length from a relaxed state to a locked state when positioned relative to a heart valve. Furthermore, an alignment member (5) is provided to achieve a desired positioning relative to the heart valve. Embolic protection (8) is also provided.
Description
The present application is a divisional application of the invention patent application having application number 201280033969.8, application date 2012, 5/7, entitled "device for delivering a medical device to a heart valve".
Technical Field
The present invention relates generally to the field of medical devices. In particular, the present invention relates to the positioning and procedure of catheters for delivering medical devices, and more particularly to the transvascular delivery of medical devices to heart valves.
Background
The human heart is a hollow muscular organ responsible for pumping large volumes of blood throughout the body on a daily basis. The ability to pump blood is facilitated by several heart valves that open and close appropriately to allow blood to pass through the heart. Cardiac valve insufficiency due to congenital defects or increased incidence of heart disease often requires treatment of the valve for insufficiency, where the primary treatment is mechanical adjustment of the valve or complete replacement of the valve. The current medical technology is intended to move from open major cardiac surgery, which is severely traumatic to the patient, to more minimally invasive catheter-based surgery, which is a less traumatic, but more complex procedure.
Catheter-based procedures require precise positioning of the catheter used to deliver, for example, a replacement valve, at an optimal location relative to the heart valve to be treated. This is particularly important when misalignment has the potential to damage adjacent cardiac structures, resulting in serious coronary complications. The placement of the catheter adjacent the heart valve is hindered by the fact that the heart continues to pump throughout the procedure, creating a significant level of turbulence that the catheter must overcome to maintain its position. In addition, clotting of the blood leading to emboli is a continuing threat as it potentially leads to serious complications such as stroke.
In us patent application 2009/0030510a1, it is disclosed that a significant obstacle to replacing the aortic valve is the accurate placement of a medical device for replacing the aortic valve. The solution taught to this problem is a Temporary Aortic Valve (TAV) device. This is a catheter with multiple balloons at the distal end that can be inflated to stabilize the position of the TAV by applying pressure directly to the aortic wall of the patient. In addition, the valve adjustment tool can be passed through the lumen of the TAV. Blood is allowed to pass between the balloons to simulate aortic valve function. The device is designed for ablation and replacement of the aortic valve, wherein the balloon of the TAV is inflated throughout the procedure to facilitate storage against the arterial wall.
The balloon is inflated throughout the medical procedure. This potentially causes a number of undesirable problems as the balloon obstructs blood flow by limiting the available cross-section for blood flow to the aortic lumen. For example, the amount of deliverable blood during surgery can be reduced with potentially dire consequences to the patient. Upstream of the restriction formed by the inflated balloon, blood pressure may increase. When the balloon is inflated in the aortic lumen for a long time, it may dislocate, for example, due to increased blood pressure upstream thereof.
WO 2006/029370 and US 2009/0287182 disclose expandable transluminal catheters. The distal end of the cannula remains in the first low cross-sectional configuration during advancement through the atrial septum to the left atrium. The distal end of the cannula is inflated using a radial dilator (balloon) to dilate the hole in the tissue of the atrial septum. The problem is that the device is not stable enough for a secure positioning. The radial expansion is merely to allow the hole to heal more thoroughly, rather than cutting a large hole from the outset.
US2005/0085842 discloses an expandable guide sleeve. The sleeve is advanced into the blood vessel in a contracted state and expanded to an expanded state to define a lumen. The inflated lumen is used to deliver fluids or instruments. Also in this prior art, the problem is that the device is not sufficiently stable for a secure positioning.
Accordingly, improved or alternative medical devices and procedures for stabilizing an introducer sheath during heart valve replacement would be advantageous, particularly to impart increased cost-effectiveness and/or patient safety.
Disclosure of Invention
Accordingly, embodiments of the present invention preferably seek to mitigate, alleviate or eliminate one or more deficiencies, disadvantages or issues in the art, such as the above-identified, singly or in any combination by providing a medical device and a method according to the appended patent claims of the invention.
The present invention is an introducer sheath that overcomes the positioning problems faced by existing catheters by using a locking system that locks the catheter to hold it in the desired anatomical position. In addition to maintaining position, the present invention is designed to minimize obstruction to blood flow and provides for deployment of an embolic capture device to reduce the risk of embolism, for example, by debris from the treatment of stenotic valves.
According to a first aspect, a catheter device for transvascular delivery of a medical device to a heart valve region of a patient is provided. The catheter device includes: an elongate cannula having a lumen and a distal end; and an elongate member having a distal end portion comprising a plurality of radially expandable cells, wherein the elongate member is retractably insertable within the lumen, the expandable cells being arranged for temporarily positioning the elongate sleeve relative to the heart valve. The elongate sleeve comprises a releasable locking member for controllably locking the elongate sleeve in shape from a relaxed state to a locked state at least partially along its length when positioned relative to the heart valve by the expandable unit.
In a second aspect, a method of transvascularly delivering a medical device to a heart valve of a patient is provided. The method comprises the following steps: providing a catheter comprising an elongated cannula having a lumen in a relaxed state and minimally invasively guiding the catheter into the vasculature; navigating a distal end of the elongate cannula through the vasculature to the heart valve; inserting the elongate member having a distal end portion comprising a plurality of radially expandable cells into the lumen of the elongate cannula; advancing the elongate member through the elongate cannula to the distal end of the elongate cannula; radially expanding the expandable unit to temporarily position the elongate sheath relative to the valve; releasing a locking member of the catheter to maintain the elongate cannula in a locked state; retracting the expandable unit and withdrawing the elongate member from the lumen of the elongate sheath; delivering a medical device to the heart valve through the lumen of the locked elongate sheath; releasing the locking member to return the elongate cannula to the relaxed state; and withdrawing the elongate cannula from the patient's vasculature in the relaxed state.
Further embodiments of the invention are defined in the dependent claims, wherein features for the second and subsequent aspects of the invention have been made mutatis mutandis to the first aspect.
It should be emphasized that the term "comprises/comprising" when used in this specification is taken to specify the presence of stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps, components or groups thereof.
Drawings
These and other aspects, features and advantages which can be achieved by embodiments of the present invention will become apparent from and elucidated with reference to the following description of embodiments of the invention, with reference to the accompanying drawings, in which:
FIG. 1A is a schematic view of an elongate cannula connected to a hemostatic valve;
FIG. 1B is a schematic view of an elongate member having radially expandable units in a collapsed configuration;
FIG. 2A is a schematic view of a distal end portion of an elongate member having radially expandable units in a collapsed configuration;
FIG. 2B is a schematic view of a distal end portion of an elongate member having radially expandable units in an expanded configuration;
fig. 2C is a schematic front view of a distal end portion of an elongate member having radially expandable units in a collapsed configuration;
FIG. 2D is a schematic front view of a distal end portion of an elongate member having radially expandable units in an expanded configuration;
3A, 3B, 3C, 3D are schematic views of an embodiment of an elongate cannula in a flexible unlocked configuration;
FIG. 3E is a schematic illustration of a cross-sectional view of the elongate cannula in an unlocked state;
FIG. 3F is a schematic view of one embodiment of a cross-sectional view of an elongate cannula in a locked state;
FIG. 3G is a schematic view of another embodiment of a cross-sectional view of an elongate cannula in a locked state;
FIG. 4A is a schematic view of an elongated cannula for transaxillary (transaxillary) delivery to a heart valve with an embolic protection filter deployed and the cannula in a relaxed state;
FIG. 4B is a schematic view with a relaxed sleeve positioned relative to a heart valve by an expandable unit of an elongate member extending outside a distal end of the sleeve;
FIG. 4C is a schematic illustration of a cross-sectional view of an elongate cannula employing a second passageway for delivery of an embolic protection filter;
FIG. 4D is a schematic view of an elongate sheath delivered transaxillary to a heart valve with the sheath in a locked configuration for placement relative to an aortic heart valve and with the expandable unit withdrawn after positioning of the sheath;
fig. 4E is a schematic view of an elongate sheath delivered to a heart valve via the femoral artery (transfemorally), with an embolic protection filter deployed and the sheath in a locked configuration;
FIG. 4F is a schematic view of an elongate sleeve delivered transaxillary to a heart valve, and wherein the relaxed sleeve is positioned relative to the heart valve by an expandable unit of the sleeve;
fig. 4G is a schematic view of an elongate cannula delivered transaxillary to a heart valve, and wherein an embolic protection filter is deployed over a blood vessel in the aortic arch via a second passageway of the cannula;
fig. 4H is a schematic view of an elongate cannula being delivered trans-femoral to a heart valve and with an embolic protection filter deployed over a blood vessel in the aortic arch via a second passageway of the cannula; and
fig. 5 is a flow chart of a method of implanting a medical device.
Detailed Description
Specific embodiments of the present invention will now be described with reference to the accompanying drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The terminology used in the detailed description of the embodiments illustrated in the accompanying drawings is not intended to be limiting of the invention. In the drawings, like numbering represents like elements.
In an embodiment of the invention according to fig. 1A, a catheter device 1 for transvascular delivery of a medical device to a heart valve region 6 (see e.g. fig. 4D) of a patient is shown. The catheter device comprises an elongate cannula 2 having a lumen and a distal end 3. Furthermore, in fig. 1B, the elongate member 4 is provided with a distal end portion 9 comprising a plurality of radially expandable cells 5. The end 9 may comprise an obturator. The expandable unit 5 is arranged for temporarily positioning the elongate sheath 2 relative to the heart valve 6, see fig. 4B and 4F. The elongate member 4 is retractably insertable into the lumen of the elongate sleeve 2, and the elongate sleeve 2 comprises a releasable locking member for controllably locking the shape of the elongate sleeve 2 at least partially along its length from a relaxed state (see fig. 3B and 4A-B, 4F) to a locked state (see fig. 3C-D and 4D-E, 4G-H) when positioned by the expandable unit 5 relative to the heart valve 6.
The elongate cannula 2 depicted in fig. 1A is designed to be capable of transvascular delivery in a relaxed state, which facilitates optimal flexibility in delivery through the vasculature. When in the desired anatomical position, the elongate sheath 2, when positioned by said expandable unit 5 relative to the heart valve 6 (as can be seen in fig. 4D-E), can be transferred from the relaxed state to the locked state by actuation of the locking member, which facilitates optimal stabilization of the catheter 1 for subsequent fixation of the medical device to the heart valve 6.
Fig. 4A shows the elongate cannula inserted in its relaxed shape. Fig. 4B shows the radially expandable unit 5 in its expanded configuration (i.e. outside the elongate sheath 2), which positions the elongate sheath 2 centrally over the valve 6. The expandable unit 5 is expanded outside the elongate member 4, the elongate member 4 extending beyond the distal end of the cannula 2. The elongate sleeve 2 is then in its locked state by the locking member and the elongate member 4 can be retracted from the lumen of the elongate sleeve 2 together with the collapsed plurality of radially expandable units 5, as can be seen in fig. 4D-E. The sleeve 2 is now positioned and stabilized over the valve 6. This overcomes the problem of lack of stability and precision positioning in the prior art. Merely providing an expandable catheter does not provide as much stability as the locking member of the cannula 2. Expandable catheters have another use, namely, to provide an accessible lumen or to dilate a septum perforation. Furthermore, the expandable member of the previous catheter is only used to provide the expansion described above, and not to center the catheter over the valve as provided by the catheter 1. When the elongate sleeve 2 is locked and when the elongate member 4 is retracted, the lumen of the elongate sleeve 2 is accessible for delivering a medical device to the region of the heart valve 6.
Alternatively or in addition, an inflatable unit, such as a balloon, may be arranged on the outside of the cannula 2. The expandable unit may be integrally formed with the casing, as can be seen in fig. 4F. Thus, the expandable unit does not affect the cross section of the lumen of the cannula 2. Upon returning to the unexpanded state, delivery of the medical device through the lumen of the catheter can be achieved without the need to retract the expandable cell 5, for example by deflating a balloon of the expandable cell 5.
The expandable unit allows a defined positioning of the distal end of the catheter sleeve 2 in relation to the heart valve in an anatomical structure such as a blood vessel, an atrium or a heart chamber. This allows for accurate delivery of the medical device through the catheter device.
The movement of certain anatomical structures is very limited during the cardiac cycle. For example, the aortic arch is relatively stable and the locked catheter will remain approximately in the same spatial orientation, direction and distance to the heart valve as during the final positioning provided by the expanded expandable unit 5.
The catheter may thus be positioned in the anatomy relative to the heart valve.
The catheter may be locked in a locked configuration along its entire length. Alternatively, the catheter may be locked only along its distal end. The distal portion may be, for example, a portion disposed in the ascending aorta, the aortic arch, and the descending aorta, as shown in fig. 4E. The catheter may comprise an embolic protection unit 8, such as an embolic protection filter 8. The embolic protection unit 8 can also help stabilize the distal end of the locked catheter in place relative to the heart valve when protruding out of the second lumen 7 and being apposed against the surrounding vessel wall. Thus, when the embolic protection unit 8 is expanded, it will act as an anchor for the cannula, as it prevents the cannula 2 from moving in the aortic arch due to the fixation of the second channel 7 to the cannula, where the embolic protection unit is expanded from the second channel 7. The delivery unit 13 for the embolic protection unit 8 is sufficiently rigid to give the cannula 2 an anchoring function.
Fig. 4D is a schematic view of an elongate cannula delivered transaxillary to a heart valve, here the aortic valve 6. The embolic protection filter 8 is deployed and the sleeve 2 is in a locked configuration disposed relative to the aortic heart valve 6.
Fig. 4E is a schematic view of an elongate sleeve being delivered trans-femoral to a heart valve with an embolic protection filter deployed and the sleeve in a locked configuration.
In fig. 4D and 4E, the expandable units 5 are not shown as they are either retracted from the cannula or returned to their unnoticeable unexpanded/collapsed configuration in the cannula.
In fig. 4G-H, the embolic protection filter 8 is positioned over two or three vessels, respectively, in the aortic arch.
In all configurations shown in fig. 4A-B, 4D-H, the side vessel 22 is effectively protected from embolic particles entering from the aortic arch. Embolic particles are carried with the blood flow over the embolic protection device along the aortic arch to anatomical structures that are less sensitive than the site (e.g., brain) to which some of the side vessels 22 direct the blood flow. The embolic protection unit may be a filter unit in which embolic particles are trapped. Alternatively or in addition, the embolic protection unit may allow particles to slide along the protection unit, but not pass through or be secured therein.
In embodiments such as shown in fig. 4A-H, a catheter 1 is depicted having a second channel 7, the second channel 7 extending in parallel on the outside or inside of the elongate cannula 2.
This channel 7 allows for the delivery of additional elements, such as an embolic protection device 8 or fluids to assist in the procedure for placement of the medical device, when the lumen of the elongate cannula 2 is used for the elongate member 4 or medical device.
The second channel 7 may be an integral part on the inside or outside of the elongated cannula 2. This has the advantage of being relatively inexpensive to manufacture by an extrusion process.
In fig. 4A-H, an embodiment of an expandable embolic filter 8 is depicted. The embolic protection or filtration device 8 can be extended before extending the expandable unit 5. This potentially enhances patient safety by capturing any emboli such as platelet debris resulting from the treatment of stenotic valves, and thereby reduces the potential for serious complications such as stroke. In these figures, at least a portion of expandable embolic filter 8 extends from the aperture of side passage 7 through which embolic filter 8 passes. The embolic filter may be of the type disclosed in WO 2010/026240, which is incorporated herein by reference in its entirety for various purposes. The embolic filter unit can be non-tubular and extend substantially flat in the expanded state. This provides a compact device and effectively prevents emboli from entering the side branch vessels in the aortic arch. Interaction with the side walls in the aortic arch is thus also kept to a minimum, avoiding scraping off more debris that would be transported in the blood stream. At the same time, the aortic arch remains open for unobstructed navigation of the cannula 2. The hoop basket in previous devices scrapes the vessel wall and occludes a substantial portion of the navigation space in the aortic arch.
In this context, "flat" extension means that the thickness of the device is significantly less than its longitudinal extension. Furthermore, "flat" refers to a dimension extending perpendicular to the longitudinal direction of the protective material such that blood flow through the aortic arch is not impeded by the protective device.
By having a second passage in the cannula 2, the distal end of the cannula can be properly positioned at the valve by the stabilizing and anchoring effect of the protection unit 8 extending from the second passage, while the medical device can be delivered through the lumen of the cannula without any obstruction by the protection unit 8 or e.g. an expandable unit such as a balloon, while protecting the side branch vessels of the aortic arch from emboli possibly delivered in the blood flow resulting from the surgery performed at the valve.
The catheter device 1 may comprise a delivery unit 13 connectable to the embolic filter unit 8 at a connection point 14, as shown in fig. 4G-H. The connection point 14 is arranged eccentrically at the embolic filter unit so that the delivery unit 13 can be connected eccentrically to the embolic filter unit 8. The eccentric positioning of the embolic filter unit is advantageous for deploying it through the delivery unit 13 using the cannula 2, while effectively protecting the carotid artery from emboli when the intervention is performed. Blood flow is effectively maintained unobstructed by such a compact device. The term "eccentric" as used in the context of the present application means not in the exact middle or arranged or positioned at the center. The center is, for example, the center of a circular cell, the focal point of an elliptical cell, a point on a centerline, such as the longitudinal centerline of an elongated cell, or the like. The periphery of the cell is positioned "off-center" because it is disposed at a distance relative to the center of the cell.
The elongate member 4 may be comprised of three balloons positioned radially about the longitudinal axis at equal intervals (see fig. 2C and 2D). There may be fewer or more balloons, and alternative expansion units such as expandable mechanical levers, or swelling units such as retractable sponges. The expansion unit 5 allows an optimal positioning of the elongated sleeve 2 with respect to the heart valve 6 as described above. The multi-balloon inflation unit may be inflated using various means (see fig. 2D), such as using fluidic means or, where appropriate, gas means. The balloons may also be inflated and inflated to different pressures, independently of the other inflation cells, either individually or simultaneously.
Alternatively, the elongate member 4 is retractably inserted into the lumen of the elongate cannula 2 for a length equal to the distance between the distal end 9 and the second proximal marker 10. In this embodiment, the proximal markers 10 and 11 are used to guide the positioning orientation of the distal end portion 9 and thus provide optimal alignment of the expandable unit 5 with the portion of the elongate sheath 2 to be expanded. This facilitates safe positioning at the desired valve area.
In another embodiment, the elongate cannula 2 is constructed of a radiopaque material to facilitate visualization of the elongate cannula 2, which provides optimal positioning of the elongate cannula 2 for delivery of the medical device. Alternatively, radiopaque fiducial markers on the elongate cannula 2 may be used for optimal positioning of the cannula 2 within the patient.
The embodiment shown in fig. 2A and 2B includes a guide wire 12, with the guide wire 12 being positioned first within the patient's body, which facilitates optimal delivery of the elongate cannula 2 and elongate member 4 to the desired anatomical location.
In the embodiment of fig. 3-4, the locking unit may comprise a releasable latch, but any form of pull wire, pressing mechanism or the like is conceivable, which serves to lock the elongated cannula 2 in a locked state, i.e. a rigid or semi-rigid state of the cannula, which state allows the cannula 2 to maintain a certain curvature, i.e. reduce the flexibility, and thereby fix its position relative to the anatomical structure, see e.g. fig. 4D-E. Furthermore, the thermal, electrical, magnetic or chemical properties of the material of the locking unit or the elongate cannula 2 itself may provide varying flexibility to change between the locked state and the relaxed state.
In particular embodiments, the elongate cannula is expandable when in the locked configuration. When the elongate cannula 2 is in the expanded state, release of the locking unit locks the elongate cannula 2 in the expanded state and thus maintains the optimal position of the surgically positioned medical device.
The locked elongate sleeve 2 may be used during a medical procedure to deliver a medical device to the heart valve 6, which may include a prosthetic heart valve prosthesis, an annuloplasty device, or a mitral valve clip.
The elongate cannula 2 may be an integral part of a medical system designed for transvascular delivery of a medical device to a heart valve 6 of a patient. The method depicted in fig. 5 first comprises 100 minimally invasively guiding a catheter 1 comprising an elongated cannula 2 with a lumen in a relaxed state into the vasculature of a patient via the femoral artery (see fig. 4E) or via the axillary route (see fig. 4D). Step 110 involves navigating the distal end 3 of the elongate cannula 2 through the vasculature to the desired heart valve, see fig. 4A. The next step 120 in the system involves inserting the elongate member 4 having the distal end portion 9 comprising the plurality of radially expandable units 5 into the lumen of the elongate cannula 2, after which the elongate member 4 is advanced through the elongate cannula 2 to the distal end of the elongate cannula 2, see fig. 4B.
Alternatively, the expandable unit 5 of the casing may be expanded at this stage (without introducing the elongate member 4 into the casing, see fig. 4F). Thereafter, a step 130 is initiated involving a plurality of radially expandable units 5 being radially expanded to temporarily position the elongate sheath 2 relative to the heart valve 6 (see fig. 4B and 4F).
After positioning, the locking member of the catheter is released to hold the elongate sheath 2 in the locked state (step 140). Step 150 of the system may then be performed, wherein the expandable unit 5 is then retracted and the elongate member 4 is withdrawn from the lumen of the elongate cannula 2, see fig. 4D-E. Alternatively, the expandable units 5 of the casing 2 are returned to the unexpanded state.
The embolic protection unit can then be pushed out of the second channel 7 as shown in fig. 4A-H. In this way, the side vessels are protected from embolic material, such as debris.
The medical device can now be delivered to the heart valve 6 through the lumen of the locked elongate sheath 2. This delivery is performed with high spatial accuracy. Blood flow in the lumen around the locked cannula 2 is less affected than with the inflated inflatable cell 5.
The medical device may be, for example, a heart valve repair or replacement device.
When the medical device has been delivered, release of the locking member may now be performed to return the elongate cannula 2 to the relaxed state (step 160), followed by withdrawal of the elongate cannula 2 from the vasculature of the patient in the relaxed state.
The embolic protection unit as shown in fig. 4A-H can be retracted before or after the locking member is released.
Locking the elongate sleeve 2 in the locked state (fig. 3B-D) comprises releasing the locking member when positioned by the expandable unit 5 relative to the heart valve 6 so as to controllably lock the elongate sleeve 2. This serves to maintain an optimal position for the delivery of the medical device during surgery.
To ensure optimal positioning of the elongate member 4 when inserted into the elongate cannula 2, the elongate member 4 is inserted to a length equal to the distance between the distal and proximal markers 10 of the elongate member 4. Primarily, the elongate cannula 2 will be positioned centrally with respect to the heart valve 6, which facilitates optimal delivery of the medical device, but other eccentric positions may be desirable.
The medical system is primarily used for delivering medical devices to be secured to a specific heart valve 6, including the aortic and mitral valves of a patient. After delivery of the medical device to the heart valve 6, the medical device delivery system is withdrawn through the lumen of the locked elongate sheath 2, which may be assisted when the elongate sheath 2 is in the expanded state. After removal of the medical device delivery system, the elongate cannula 2 in the locked state is transferred to the relaxed state, which facilitates facilitating retraction of the elongate cannula 2.
The invention has been described above with reference to specific embodiments. However, other embodiments than the above described are equally possible within the scope of the invention. Different method steps than those described above may be provided within the scope of the invention. The different features and steps of the invention may be combined in other combinations than those described. The catheter may be positioned and locked in other cardiac anatomies than those shown. The medical device delivered through the catheter sheath may be any medical device to be delivered to the heart valve tissue. The scope of the invention is limited only by the appended claims.
Claims (10)
1. A catheter device (1) for transvascular delivery of a medical device to a heart valve region (6) of a patient, the heart valve region (6) comprising an aortic valve of the patient, the catheter device comprising:
an elongate cannula (2) having an exterior, a lumen, a distal end, and a distal portion, the distal end of the elongate cannula (2) being configured to be disposed in an ascending aorta and having a locked configuration; and
at least one of radially expandable units (5) for apposition with tissue luminal tissue within the aortic arch when expanded, at least one of the radially expandable units (5) being arranged on the exterior of the elongated sleeve (2) at the distal end portion, and the at least one radially expandable unit (5) being configured for positioning the elongated sleeve with its distal end in an ascending aortic portion of the aortic arch, and the distal end of the elongated sleeve (2) being configured to be oriented towards, spaced a distance downstream in the blood flow direction from, and locked and centrally positioned relative to, the aortic valve when the radially expandable unit (5) is in an expanded state.
2. The catheter device of claim 1, wherein the at least one radially expandable unit is integrally formed with the elongate sheath.
3. The catheter device of claim 1 or 2, wherein the at least one radially expandable unit comprises an inflatable balloon, an inflatable mechanical lever or a swellable unit.
4. The catheter device of claim 1 or 2, wherein the at least one radially expandable unit is a plurality of radially expandable units.
5. The catheter device of claim 4, wherein the plurality of radially expandable units are positioned equally spaced about a longitudinal axis of the elongate sheath.
6. The catheter device of claim 1 or 2, wherein the elongate sleeve comprises radiopaque fiducial markers.
7. The catheter device of claim 1 or 2, wherein the medical device is a prosthetic replacement valve or a valve repair device.
8. A kit comprising a catheter device according to any of claims 1 to 7 and a medical device for a heart valve, the medical device comprising an artificial replacement valve or a valve repair device.
9. A catheter device (1) for transvascular delivery of a medical device to a heart valve region (6) of a patient, the catheter device comprising:
an elongate cannula (2) having a lumen and a distal end, the distal end having a locked configuration; and
at least one radially expandable unit disposed at a distal end of the elongate sheath, positionable in an ascending aorta of the patient, and arranged for temporarily positioning the elongate sheath relative to the heart valve when in an expanded state;
an elongate member (4) having a distal end portion comprising a plurality of radially expandable cells (5), the elongate member being retractably insertable into the lumen;
the radially expandable unit is arranged for temporarily centering the elongate sleeve relative to the heart valve when in an expanded state outside the distal end of the locked elongate sleeve; and is
Wherein the distal end of the catheter is configured to be disposed in an ascending aorta.
10. The catheter device of claim 9, wherein the elongate member is retractable from the lumen with the plurality of radially expandable units when collapsed.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161483689P | 2011-05-08 | 2011-05-08 | |
EP11165215.2 | 2011-05-08 | ||
EP11165215.2A EP2522307B1 (en) | 2011-05-08 | 2011-05-08 | Device for delivery of medical devices to a cardiac valve |
US61/483689 | 2011-05-08 | ||
CN201280033969.8A CN103841921B (en) | 2011-05-08 | 2012-05-07 | For medical treatment device being delivered to valvular device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280033969.8A Division CN103841921B (en) | 2011-05-08 | 2012-05-07 | For medical treatment device being delivered to valvular device |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106139366A CN106139366A (en) | 2016-11-23 |
CN106139366B true CN106139366B (en) | 2021-01-08 |
Family
ID=44680993
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610459051.XA Expired - Fee Related CN106139366B (en) | 2011-05-08 | 2012-05-07 | Device for delivering a medical device to a heart valve |
CN201510004048.4A Active CN104665958B (en) | 2011-05-08 | 2012-05-07 | For medical treatment device to be delivered into valvular apparatus and method |
CN201280033969.8A Expired - Fee Related CN103841921B (en) | 2011-05-08 | 2012-05-07 | For medical treatment device being delivered to valvular device |
CN201280022255.7A Active CN103717178B (en) | 2011-05-08 | 2012-05-07 | Device and method for delivery of medical devices to a cardiac valve |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510004048.4A Active CN104665958B (en) | 2011-05-08 | 2012-05-07 | For medical treatment device to be delivered into valvular apparatus and method |
CN201280033969.8A Expired - Fee Related CN103841921B (en) | 2011-05-08 | 2012-05-07 | For medical treatment device being delivered to valvular device |
CN201280022255.7A Active CN103717178B (en) | 2011-05-08 | 2012-05-07 | Device and method for delivery of medical devices to a cardiac valve |
Country Status (9)
Country | Link |
---|---|
US (7) | US10835362B2 (en) |
EP (4) | EP2522307B1 (en) |
JP (1) | JP5607276B2 (en) |
CN (4) | CN106139366B (en) |
AU (3) | AU2012269360B2 (en) |
CA (2) | CA2873567A1 (en) |
IL (1) | IL229330A0 (en) |
WO (2) | WO2012152761A2 (en) |
ZA (2) | ZA201308842B (en) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
CA3035048C (en) | 2010-12-23 | 2021-05-04 | Mark Deem | System for mitral valve repair and replacement |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
EP2522307B1 (en) * | 2011-05-08 | 2020-09-30 | ITSO Medical AB | Device for delivery of medical devices to a cardiac valve |
EP3964176A1 (en) | 2011-06-21 | 2022-03-09 | Twelve, Inc. | Prosthetic heart valve devices |
US9364326B2 (en) | 2011-06-29 | 2016-06-14 | Mitralix Ltd. | Heart valve repair devices and methods |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US10016271B2 (en) | 2011-10-19 | 2018-07-10 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
AU2012325809B2 (en) | 2011-10-19 | 2016-01-21 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
EP2732794A1 (en) | 2012-11-14 | 2014-05-21 | Contego AB | Improved embolic protection device and method |
US9669197B2 (en) * | 2012-11-15 | 2017-06-06 | Boston Scientific Scimed, Inc. | Expandable member dissection port and related methods |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
US10111747B2 (en) | 2013-05-20 | 2018-10-30 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
CN110215312A (en) * | 2014-01-10 | 2019-09-10 | 企斯动哈特有限公司 | For deflecting the device and related system of embolism |
US11278388B2 (en) * | 2014-05-21 | 2022-03-22 | Swat Medical Ab | Embolic protection device and method |
FR3021863A1 (en) * | 2014-06-05 | 2015-12-11 | Bernard Pain | TRANSCATHETER INTRODUCTION DEVICE IN THE AORTIC ROOT AT THE TUBULAR SINO JUNCTION |
US9700412B2 (en) | 2014-06-26 | 2017-07-11 | Mitralix Ltd. | Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices |
US10327862B2 (en) * | 2014-09-17 | 2019-06-25 | Covidien Lp | Fiducial marker deployment system |
US10251748B2 (en) * | 2015-02-12 | 2019-04-09 | Medtronic Vascular, Inc. | Centering devices for use with a valve prosthesis delivery system and methods of use thereof |
TWI545365B (en) * | 2015-02-17 | 2016-08-11 | 大立光電股份有限公司 | Image capturing lens assembly, image capturing device and electronic device |
EP3316819B1 (en) * | 2015-07-03 | 2020-11-11 | Symetis SA | Balloon catheter for prosthetic valves |
CN107920895B (en) | 2015-08-21 | 2020-06-26 | 托尔福公司 | Implantable heart valve devices, mitral valve repair devices, and associated systems and methods |
US10561496B2 (en) | 2015-09-16 | 2020-02-18 | Edwards Lifesciences Corporation | Perfusion balloon designs |
WO2017072262A1 (en) * | 2015-10-28 | 2017-05-04 | Koninklijke Philips N.V. | Signaling of an aortic valve state |
US10555814B2 (en) * | 2015-11-17 | 2020-02-11 | Edwards Lifesciences Corporation | Ultrasound probe for cardiac treatment |
US10433952B2 (en) | 2016-01-29 | 2019-10-08 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
US10625059B2 (en) * | 2016-02-09 | 2020-04-21 | Nadar A. Dakak | Angioplasty, self-expanding, stent catheter with low pressure anchor and/or marker balloon assembly and method |
US10646364B2 (en) * | 2016-02-09 | 2020-05-12 | Nadar A. Dakak | Catheter |
EP3448316B1 (en) | 2016-04-29 | 2023-03-29 | Medtronic Vascular Inc. | Prosthetic heart valve devices with tethered anchors |
US11771434B2 (en) * | 2016-09-28 | 2023-10-03 | Restore Medical Ltd. | Artery medical apparatus and methods of use thereof |
WO2018081239A1 (en) * | 2016-10-25 | 2018-05-03 | Gittard Shaun David | Vascular anchoring introducer sheath |
EP3541462A4 (en) | 2016-11-21 | 2020-06-17 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
US10653523B2 (en) | 2017-01-19 | 2020-05-19 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
CA3054891A1 (en) * | 2017-03-03 | 2018-09-07 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US12029647B2 (en) | 2017-03-07 | 2024-07-09 | 4C Medical Technologies, Inc. | Systems, methods and devices for prosthetic heart valve with single valve leaflet |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
EP3403615A1 (en) * | 2017-05-17 | 2018-11-21 | Aorticlab Sarl | Transcatheter valve prosthesis for blood vessel |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
US12036113B2 (en) | 2017-06-14 | 2024-07-16 | 4C Medical Technologies, Inc. | Delivery of heart chamber prosthetic valve implant |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10856984B2 (en) | 2017-08-25 | 2020-12-08 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
CN108371570B (en) * | 2017-10-24 | 2023-10-31 | 杭州启明医疗器械股份有限公司 | Interventional heart valve recyclable conveying system with stable operation |
CN108211089A (en) * | 2017-12-30 | 2018-06-29 | 苏州茵络医疗器械有限公司 | Across valve device and its application method |
CN109965974A (en) * | 2018-03-19 | 2019-07-05 | 杭州诺生医疗科技有限公司 | Atrial septum ostomy appliance through intubation intervention |
WO2019238964A1 (en) * | 2018-06-14 | 2019-12-19 | Itso Medical Ab | Devices and methods for transvascular delivery of medical devices |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
AU2019374743B2 (en) | 2018-11-08 | 2022-03-03 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
CN109223135A (en) * | 2018-11-14 | 2019-01-18 | 无锡市人民医院 | Guiding sheath group and catheter sheath in aorta |
MX2021007034A (en) * | 2018-12-15 | 2021-10-22 | Eric Raul Guerra | Thrombectomy catheter and methods of use. |
US11850381B2 (en) * | 2019-01-18 | 2023-12-26 | Becton, Dickinson And Company | Intravenous therapy system having a needle hub and catheter hub |
EP3934591A4 (en) | 2019-03-08 | 2022-11-23 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
JP7438236B2 (en) | 2019-04-01 | 2024-02-26 | ニオバスク ティアラ インコーポレイテッド | Controllably deployable prosthetic valve |
CA3136334A1 (en) | 2019-04-10 | 2020-10-15 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
CN114025813B (en) | 2019-05-20 | 2024-05-14 | 内奥瓦斯克迪亚拉公司 | Introducer with hemostatic mechanism |
CN114144144A (en) | 2019-06-20 | 2022-03-04 | 内奥瓦斯克迪亚拉公司 | Low-profile prosthetic mitral valve |
US11707351B2 (en) | 2019-08-19 | 2023-07-25 | Encompass Technologies, Inc. | Embolic protection and access system |
CN112353526A (en) * | 2019-12-25 | 2021-02-12 | 上海微创医疗器械(集团)有限公司 | Plug protection device |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US12053375B2 (en) | 2020-03-05 | 2024-08-06 | 4C Medical Technologies, Inc. | Prosthetic mitral valve with improved atrial and/or annular apposition and paravalvular leakage mitigation |
US11992403B2 (en) | 2020-03-06 | 2024-05-28 | 4C Medical Technologies, Inc. | Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells |
CN114738553B (en) * | 2022-04-18 | 2024-08-16 | 中建八局第二建设有限公司 | Pipeline centering construction method and centering device |
Family Cites Families (147)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH668192A5 (en) * | 1985-11-29 | 1988-12-15 | Schneider Medintag Ag | CATHETER FOR TREATING NARROW BODIES, FOR EXAMPLE IN A BLOOD VESSEL. |
US4850358A (en) * | 1986-11-14 | 1989-07-25 | Millar Instruments, Inc. | Method and assembly for introducing multiple devices into a biological vessel |
US4893613A (en) * | 1987-11-25 | 1990-01-16 | Hake Lawrence W | Endoscope construction with means for controlling rigidity and curvature of flexible endoscope tube |
US5329923A (en) * | 1991-02-15 | 1994-07-19 | Lundquist Ingemar H | Torquable catheter |
US6866650B2 (en) * | 1991-07-16 | 2005-03-15 | Heartport, Inc. | System for cardiac procedures |
US5766151A (en) * | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5558644A (en) * | 1991-07-16 | 1996-09-24 | Heartport, Inc. | Retrograde delivery catheter and method for inducing cardioplegic arrest |
US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US5769812A (en) * | 1991-07-16 | 1998-06-23 | Heartport, Inc. | System for cardiac procedures |
US5584803A (en) * | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US6029671A (en) * | 1991-07-16 | 2000-02-29 | Heartport, Inc. | System and methods for performing endovascular procedures |
US5795325A (en) * | 1991-07-16 | 1998-08-18 | Heartport, Inc. | Methods and apparatus for anchoring an occluding member |
US5190050A (en) * | 1991-11-08 | 1993-03-02 | Electro-Catheter Corporation | Tip deflectable steerable catheter |
US5505702A (en) * | 1992-04-09 | 1996-04-09 | Scimed Life Systems, Inc. | Balloon catheter for dilatation and perfusion |
US5263932A (en) * | 1992-04-09 | 1993-11-23 | Jang G David | Bailout catheter for fixed wire angioplasty |
US5357979A (en) * | 1992-12-01 | 1994-10-25 | Intelliwire, Inc. | Flexible elongate device having a distal extremity with current controlled adjustable stiffness and adjustable bend location and method |
US6283127B1 (en) * | 1992-12-03 | 2001-09-04 | Wesley D. Sterman | Devices and methods for intracardiac procedures |
US5797960A (en) * | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5645529A (en) * | 1993-03-11 | 1997-07-08 | C. R. Bard, Inc. | Devices for selectively directing inflation devices |
US5336184A (en) * | 1993-07-15 | 1994-08-09 | Teirstein Paul S | Rapid exchange catheter |
US6196996B1 (en) * | 1993-07-15 | 2001-03-06 | Paul S. Teirstein | Irradiation catheter and method of use |
US5656011A (en) * | 1994-04-28 | 1997-08-12 | Epflex Feinwerktechnik Gmbh | Endoscope tube system |
US5571085A (en) * | 1995-03-24 | 1996-11-05 | Electro-Catheter Corporation | Steerable open lumen catheter |
AU5189496A (en) * | 1995-03-30 | 1996-10-16 | Heartport, Inc. | Endovascular cardiac venting catheter and method |
US5678570A (en) * | 1995-04-14 | 1997-10-21 | The University Of North Carolina At Chapel Hill | Method of treating cardiac arrest |
US5666970A (en) * | 1995-05-02 | 1997-09-16 | Heart Rhythm Technologies, Inc. | Locking mechanism for catheters |
US6152909A (en) * | 1996-05-20 | 2000-11-28 | Percusurge, Inc. | Aspiration system and method |
NL1003529C2 (en) * | 1996-07-05 | 1998-01-07 | Optische Ind Oede Oude Delftoe | Catheter with centering means. |
US5947924A (en) * | 1996-09-13 | 1999-09-07 | Angiorad, L.L.C. | Dilatation/centering catheter used for the treatment of stenosis or other constriction in a bodily passageway and method thereof |
US5843027A (en) * | 1996-12-04 | 1998-12-01 | Cardiovascular Dynamics, Inc. | Balloon sheath |
US6117064A (en) * | 1997-01-06 | 2000-09-12 | Apple; Marc G. | Catheter system |
US5868708A (en) * | 1997-05-07 | 1999-02-09 | Applied Medical Resources Corporation | Balloon catheter apparatus and method |
US6340356B1 (en) * | 1997-09-23 | 2002-01-22 | NAVIA JOSé ANTONIO | Intraluminal catheter with expandable tubular open-walled element |
US5938582A (en) * | 1997-09-26 | 1999-08-17 | Medtronic, Inc. | Radiation delivery centering catheter |
US6371935B1 (en) * | 1999-01-22 | 2002-04-16 | Cardeon Corporation | Aortic catheter with flow divider and methods for preventing cerebral embolization |
US6361545B1 (en) * | 1997-09-26 | 2002-03-26 | Cardeon Corporation | Perfusion filter catheter |
US6395014B1 (en) * | 1997-09-26 | 2002-05-28 | John A. Macoviak | Cerebral embolic protection assembly and associated methods |
US6190356B1 (en) * | 1997-10-20 | 2001-02-20 | Robert M. Bersin | Helical spiral balloon catheter |
US6139517A (en) * | 1997-12-15 | 2000-10-31 | Cardeon Corporation | Perfusion shunt apparatus and method |
US6695864B2 (en) * | 1997-12-15 | 2004-02-24 | Cardeon Corporation | Method and apparatus for cerebral embolic protection |
US6338709B1 (en) * | 1998-02-19 | 2002-01-15 | Medtronic Percusurge, Inc. | Intravascular radiation therapy device and method of use |
US6267747B1 (en) * | 1998-05-11 | 2001-07-31 | Cardeon Corporation | Aortic catheter with porous aortic root balloon and methods for inducing cardioplegic arrest |
AU5333599A (en) * | 1998-08-06 | 2000-02-28 | Cardeon Corporation | Aortic catheter with porous aortic arch balloon and methods for selective aorticperfusion |
US6051014A (en) * | 1998-10-13 | 2000-04-18 | Embol-X, Inc. | Percutaneous filtration catheter for valve repair surgery and methods of use |
US6896690B1 (en) * | 2000-01-27 | 2005-05-24 | Viacor, Inc. | Cardiac valve procedure methods and devices |
US6425916B1 (en) * | 1999-02-10 | 2002-07-30 | Michi E. Garrison | Methods and devices for implanting cardiac valves |
US6743196B2 (en) * | 1999-03-01 | 2004-06-01 | Coaxia, Inc. | Partial aortic occlusion devices and methods for cerebral perfusion augmentation |
US20040044350A1 (en) * | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US7744613B2 (en) * | 1999-06-25 | 2010-06-29 | Usgi Medical, Inc. | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US7637905B2 (en) * | 2003-01-15 | 2009-12-29 | Usgi Medical, Inc. | Endoluminal tool deployment system |
US6142987A (en) * | 1999-08-03 | 2000-11-07 | Scimed Life Systems, Inc. | Guided filter with support wire and methods of use |
US7018406B2 (en) * | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US6974411B2 (en) * | 2000-04-03 | 2005-12-13 | Neoguide Systems, Inc. | Endoscope with single step guiding apparatus |
JP4538918B2 (en) * | 2000-08-02 | 2010-09-08 | 株式会社カネカ | Medical catheter for treating part of a body tube with ionizing radiation |
US6537294B1 (en) * | 2000-10-17 | 2003-03-25 | Advanced Cardiovascular Systems, Inc. | Delivery systems for embolic filter devices |
US6482228B1 (en) * | 2000-11-14 | 2002-11-19 | Troy R. Norred | Percutaneous aortic valve replacement |
US7169165B2 (en) * | 2001-01-16 | 2007-01-30 | Boston Scientific Scimed, Inc. | Rapid exchange sheath for deployment of medical devices and methods of use |
US7556646B2 (en) * | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
US20030050662A1 (en) * | 2001-09-07 | 2003-03-13 | Don Michael T. Anthony | Devices for observing and treating body passages |
US6887257B2 (en) * | 2001-10-19 | 2005-05-03 | Incept Llc | Vascular embolic filter exchange devices and methods of use thereof |
CA2759746C (en) | 2001-12-05 | 2018-05-22 | Smt Research And Development Ltd. | Endovascular device for entrapment of particulate matter and method for use |
US20040127813A1 (en) * | 2001-12-21 | 2004-07-01 | Schwamm Lee H | Dual balloon catheter with sensor for continuous transvenous measurement of intracranial pressure |
US7493156B2 (en) * | 2002-01-07 | 2009-02-17 | Cardiac Pacemakers, Inc. | Steerable guide catheter with pre-shaped rotatable shaft |
US20040158229A1 (en) * | 2002-01-24 | 2004-08-12 | Quinn David G. | Catheter assembly and method of catheter insertion |
US7025759B2 (en) * | 2002-02-04 | 2006-04-11 | Ebi, L.P. | Steerable catheter |
US6997938B2 (en) * | 2002-02-12 | 2006-02-14 | Scimed Life Systems, Inc. | Embolic protection device |
US20030158574A1 (en) * | 2002-02-15 | 2003-08-21 | Esch Brady D. | Flow-through aortic flow divider for cerebral and coronary embolic protection |
AU2003268379A1 (en) * | 2002-09-03 | 2004-03-29 | John R. Fagan | Arterial embolic filter deployed from catheter |
JP2006508776A (en) * | 2002-09-20 | 2006-03-16 | フローメディカ,インコーポレイテッド | Method and apparatus for selective substance delivery via an intrarenal catheter |
WO2004043273A2 (en) * | 2002-11-13 | 2004-05-27 | Rosengart Todd K | Apparatus and method for cutting a heart valve |
US20070260225A1 (en) * | 2002-11-15 | 2007-11-08 | Applied Medical Resources Corporation | Steerable sheath actuator |
US20050256452A1 (en) * | 2002-11-15 | 2005-11-17 | Demarchi Thomas | Steerable vascular sheath |
US20050004515A1 (en) * | 2002-11-15 | 2005-01-06 | Hart Charles C. | Steerable kink resistant sheath |
US6945957B2 (en) * | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US7637920B2 (en) * | 2003-03-28 | 2009-12-29 | Ev3 Inc. | Double ended intravascular medical device |
US7591832B2 (en) * | 2003-04-24 | 2009-09-22 | Medtronic, Inc. | Expandable guide sheath and apparatus with distal protection and methods for use |
US8388628B2 (en) * | 2003-04-24 | 2013-03-05 | Medtronic, Inc. | Expandable sheath for delivering instruments and agents into a body lumen and methods for use |
DE602004023350D1 (en) * | 2003-04-30 | 2009-11-12 | Medtronic Vascular Inc | Percutaneous inserted provisional valve |
US7604650B2 (en) * | 2003-10-06 | 2009-10-20 | 3F Therapeutics, Inc. | Method and assembly for distal embolic protection |
US10219899B2 (en) * | 2004-04-23 | 2019-03-05 | Medtronic 3F Therapeutics, Inc. | Cardiac valve replacement systems |
US7651514B2 (en) * | 2003-12-11 | 2010-01-26 | Boston Scientific Scimed, Inc. | Nose rider improvement for filter exchange and methods of use |
US20050137696A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical | Apparatus and methods for protecting against embolization during endovascular heart valve replacement |
US8603160B2 (en) * | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US20090132035A1 (en) * | 2004-02-27 | 2009-05-21 | Roth Alex T | Prosthetic Heart Valves, Support Structures and Systems and Methods for Implanting the Same |
JP4764417B2 (en) * | 2004-03-23 | 2011-09-07 | ボストン サイエンティフィック リミテッド | In vivo visualization system |
US20060074485A1 (en) * | 2004-05-17 | 2006-04-06 | Fidel Realyvasquez | Method and apparatus for percutaneous valve repair |
US20060135962A1 (en) * | 2004-09-09 | 2006-06-22 | Kick George F | Expandable trans-septal sheath |
US8052592B2 (en) * | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
EP3593760B1 (en) * | 2004-10-02 | 2021-03-31 | Edwards Lifesciences CardiAQ LLC | Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support (ii) |
US20060129130A1 (en) * | 2004-11-18 | 2006-06-15 | Tal Michael G | Sheath/catheter system with controlled hardness and flexibility |
CN101184454B (en) * | 2005-03-25 | 2010-10-20 | 安普尔医药公司 | Devices, systems, and methods for reshaping a heart valve annulus |
US20060259066A1 (en) * | 2005-04-28 | 2006-11-16 | Euteneuer Charles L | Bifurcated artery filter system |
US20060287668A1 (en) * | 2005-06-16 | 2006-12-21 | Fawzi Natalie V | Apparatus and methods for intravascular embolic protection |
US8790396B2 (en) * | 2005-07-27 | 2014-07-29 | Medtronic 3F Therapeutics, Inc. | Methods and systems for cardiac valve delivery |
US7998132B2 (en) * | 2005-09-02 | 2011-08-16 | Boston Scientific Scimed, Inc. | Adjustable stiffness catheter |
US8778017B2 (en) * | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US9259317B2 (en) * | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
CN1961847A (en) * | 2005-11-09 | 2007-05-16 | 温宁 | Artificial heart valve with scaffold and delivery apparatus thereof |
CN2855366Y (en) * | 2005-11-09 | 2007-01-10 | 王蓉珍 | Artificial cardiac valves stand and its delivery placer |
US8876772B2 (en) * | 2005-11-16 | 2014-11-04 | Boston Scientific Scimed, Inc. | Variable stiffness shaft |
US8066664B2 (en) * | 2005-12-12 | 2011-11-29 | Taheri Laduca Llc | Tri-directional articulating catheter |
WO2007076045A2 (en) * | 2005-12-24 | 2007-07-05 | Crossman Arthur W | Circumferential ablation guide wire system and related method of using the same |
US9962066B2 (en) * | 2005-12-30 | 2018-05-08 | Intuitive Surgical Operations, Inc. | Methods and apparatus to shape flexible entry guides for minimally invasive surgery |
US20080097399A1 (en) * | 2006-06-15 | 2008-04-24 | Ravish Sachar | Catheter With Adjustable Stiffness |
US8109953B1 (en) * | 2006-08-14 | 2012-02-07 | Volcano Corporation | Catheter device, hub assembly and method for traversing total occlusions |
US9480548B2 (en) * | 2006-09-11 | 2016-11-01 | Edwards Lifesciences Ag | Embolic protection device and method of use |
US8460335B2 (en) * | 2006-09-11 | 2013-06-11 | Embrella Cardiovascular, Inc. | Method of deflecting emboli from the cerebral circulation |
US20100179584A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of diverting embolic debris away from the cerebral circulation |
US20080172037A1 (en) * | 2006-11-01 | 2008-07-17 | Percutaneous Systems, Inc. | Catheter with adjustable column stability and methods for its use |
US8858584B2 (en) * | 2006-11-07 | 2014-10-14 | Cook Medical Technologies Llc | Emergency transection device |
WO2008066881A1 (en) * | 2006-11-29 | 2008-06-05 | Amir Belson | Embolic protection device |
WO2008073964A2 (en) * | 2006-12-12 | 2008-06-19 | Spence Paul A | Implant, systems and methods for physically diverting material in blood flow away form the head |
EP1935378B1 (en) * | 2006-12-19 | 2014-09-17 | Sorin Group Italia S.r.l. | Instrument for in situ positioning of cardiac valve prostheses |
US8070799B2 (en) * | 2006-12-19 | 2011-12-06 | Sorin Biomedica Cardio S.R.L. | Instrument and method for in situ deployment of cardiac valve prostheses |
JP5604110B2 (en) * | 2007-02-05 | 2014-10-08 | ボストン サイエンティフィック リミテッド | System for delivering a valve |
AU2008269018B2 (en) * | 2007-06-26 | 2014-07-31 | St. Jude Medical, Inc. | Apparatus and methods for implanting collapsible/expandable prosthetic heart valves |
EP2020658B1 (en) | 2007-06-29 | 2014-06-18 | Semiconductor Energy Laboratory Co., Ltd. | Semiconductor memory device and semiconductor device |
US8663319B2 (en) | 2007-07-23 | 2014-03-04 | Hocor Cardiovascular Technologies Llc | Methods and apparatus for percutaneous aortic valve replacement |
US8663318B2 (en) * | 2007-07-23 | 2014-03-04 | Hocor Cardiovascular Technologies Llc | Method and apparatus for percutaneous aortic valve replacement |
US20090216284A1 (en) * | 2007-08-27 | 2009-08-27 | Singfatt Chin | Balloon cannula system for accessing and visualizing spine and related methods |
US8292907B2 (en) * | 2007-08-31 | 2012-10-23 | Cook Medical Technologies Llc | Balloon assisted occlusion device |
US8114154B2 (en) * | 2007-09-07 | 2012-02-14 | Sorin Biomedica Cardio S.R.L. | Fluid-filled delivery system for in situ deployment of cardiac valve prostheses |
US20090131785A1 (en) * | 2007-11-15 | 2009-05-21 | University Of Florida Research Foundation, Inc. | Variable occlusional balloon catheter assembly |
CN103961193A (en) * | 2007-12-18 | 2014-08-06 | 因特尔赛克特耳鼻喉公司 | Self-expanding devices and methods therefor |
EP2072027B1 (en) * | 2007-12-21 | 2020-06-17 | Medtentia International Ltd Oy | pre-annuloplasty device and method |
US20090264820A1 (en) * | 2008-04-16 | 2009-10-22 | Abiomed, Inc. | Method and apparatus for implanting an endoluminal prosthesis such as a prosthetic valve |
US9061119B2 (en) * | 2008-05-09 | 2015-06-23 | Edwards Lifesciences Corporation | Low profile delivery system for transcatheter heart valve |
US8668668B2 (en) * | 2008-05-14 | 2014-03-11 | Onset Medical Corporation | Expandable iliac sheath and method of use |
JP5762955B2 (en) * | 2008-06-23 | 2015-08-12 | ルーメン・バイオメディカル・インコーポレイテッドLumen Biomedical, Inc. | Embolization prevention during percutaneous heart valve replacement and similar procedures |
US9101735B2 (en) * | 2008-07-07 | 2015-08-11 | Intuitive Surgical Operations, Inc. | Catheter control systems |
KR101772089B1 (en) * | 2008-09-04 | 2017-08-28 | 앤덜스 존슨 | Temporary embolic protection device and medical procedure for delivery thereof |
BRPI0919195A2 (en) * | 2008-09-18 | 2019-09-24 | Acclarent Inc | Methods and Apparatus for the Treatment of Ear, Nose, and Throat Disorders |
US8852225B2 (en) * | 2008-09-25 | 2014-10-07 | Medtronic, Inc. | Emboli guarding device |
US7951111B2 (en) * | 2008-10-10 | 2011-05-31 | Intervalve, Inc. | Valvuloplasty catheter and methods |
US8388644B2 (en) * | 2008-12-29 | 2013-03-05 | Cook Medical Technologies Llc | Embolic protection device and method of use |
EP2391303A4 (en) * | 2009-01-29 | 2020-09-09 | Boston Scientific Scimed, Inc. | Illuminated intravascular blood filter |
US20100228280A1 (en) * | 2009-03-09 | 2010-09-09 | Adam Groothuis | Methods and devices for treatment of lumenal systems |
US8876877B2 (en) * | 2009-04-23 | 2014-11-04 | Medtronic Vascular, Inc. | Centering for a TAA |
US8323241B2 (en) * | 2009-06-24 | 2012-12-04 | Shifamed Holdings, Llc | Steerable medical delivery devices and methods of use |
US20110027038A1 (en) | 2009-07-28 | 2011-02-03 | Pen-Chun YU | Heat sink anchoring apparatus |
WO2011132080A2 (en) * | 2010-03-23 | 2011-10-27 | Gardia Medical Ltd | Embolic protection devices, vascular delivery catheters, and methods of deploying same |
US8899225B2 (en) * | 2011-01-19 | 2014-12-02 | Cook Medical Technologies Llc | Percutaneous dilational device having balloon retention mechanism |
US20120209375A1 (en) * | 2011-02-11 | 2012-08-16 | Gilbert Madrid | Stability device for use with percutaneous delivery systems |
EP2522307B1 (en) * | 2011-05-08 | 2020-09-30 | ITSO Medical AB | Device for delivery of medical devices to a cardiac valve |
US8251942B1 (en) * | 2011-12-19 | 2012-08-28 | Ibrahim Rashid Al-Rashdan | System and method for removing blood containing contrast dye |
EP2800602B1 (en) * | 2012-01-06 | 2017-08-02 | Emboline, Inc. | Integrated embolic protection devices |
EP2732794A1 (en) * | 2012-11-14 | 2014-05-21 | Contego AB | Improved embolic protection device and method |
-
2011
- 2011-05-08 EP EP11165215.2A patent/EP2522307B1/en active Active
-
2012
- 2012-05-07 EP EP15156079.4A patent/EP2946751B8/en active Active
- 2012-05-07 CN CN201610459051.XA patent/CN106139366B/en not_active Expired - Fee Related
- 2012-05-07 CN CN201510004048.4A patent/CN104665958B/en active Active
- 2012-05-07 US US14/115,089 patent/US10835362B2/en active Active
- 2012-05-07 AU AU2012269360A patent/AU2012269360B2/en not_active Ceased
- 2012-05-07 AU AU2012252466A patent/AU2012252466B2/en active Active
- 2012-05-07 EP EP12718274.9A patent/EP2713953A1/en not_active Withdrawn
- 2012-05-07 CN CN201280033969.8A patent/CN103841921B/en not_active Expired - Fee Related
- 2012-05-07 CN CN201280022255.7A patent/CN103717178B/en active Active
- 2012-05-07 CA CA2873567A patent/CA2873567A1/en not_active Abandoned
- 2012-05-07 WO PCT/EP2012/058384 patent/WO2012152761A2/en active Application Filing
- 2012-05-07 EP EP12718273.1A patent/EP2693984B1/en active Active
- 2012-05-07 US US14/115,088 patent/US9023101B2/en active Active
- 2012-05-07 CA CA2836733A patent/CA2836733C/en active Active
- 2012-05-07 JP JP2014509701A patent/JP5607276B2/en active Active
- 2012-05-07 WO PCT/EP2012/058385 patent/WO2012171720A1/en active Application Filing
-
2013
- 2013-11-07 IL IL229330A patent/IL229330A0/en active IP Right Grant
- 2013-11-25 ZA ZA2013/08842A patent/ZA201308842B/en unknown
- 2013-11-27 ZA ZA2013/08917A patent/ZA201308917B/en unknown
-
2015
- 2015-03-31 US US14/675,483 patent/US10433946B2/en active Active
-
2017
- 2017-04-18 AU AU2017202490A patent/AU2017202490B2/en not_active Ceased
-
2019
- 2019-09-04 US US16/560,194 patent/US11992398B2/en active Active
-
2020
- 2020-10-09 US US17/067,461 patent/US20210022844A1/en not_active Abandoned
-
2022
- 2022-08-16 US US17/820,131 patent/US20220387162A1/en active Pending
-
2024
- 2024-05-27 US US18/675,045 patent/US20240307167A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106139366B (en) | Device for delivering a medical device to a heart valve | |
US10926065B2 (en) | Medical device, method and system for temporary occlusion of an opening in a lumen of a body | |
US9579182B2 (en) | Method for delivery of an embolic protection unit | |
US20200254227A1 (en) | Catheter Device And Method For Delivery Of Medical Devices In The Aorta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170828 Address after: Helsingborg Applicant after: Aesop Medical Inc Address before: Helsingborg Applicant before: Eger A. B. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210108 Termination date: 20210507 |
|
CF01 | Termination of patent right due to non-payment of annual fee |